Revolutionizing Wound Care With Spectral AI - See How This AI Company Is Changing Critical Diagnostics

Peter M. Carlson, CEO of Spectral AI MDAI, was recently a panelist at Benzinga's virtual event, AI Unleaded: Exploring The Possibilities.

Spectral is an AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care. Currently, it is focused on initial applications involving patients with burns and diabetic foot ulcers. The company's DeepView system is a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. 

Learn more here:

Featured photo by National Cancer Institute on Unsplash.

This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.